Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers

Hepatocellular carcinoma (HCC), the most common type of liver cancer, is derived mostly from a background of chronic inflammation. Multiple immunotherapeutic strategies have been evaluated in HCC, with some degree of success, particularly with immune checkpoint blockade (ICB). Despite the initial en...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, David, Choo, Su Pin, Chew, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966558/
https://www.ncbi.nlm.nih.gov/pubmed/31816940
http://dx.doi.org/10.3390/cancers11121926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966558/
https://www.ncbi.nlm.nih.gov/pubmed/31816940
http://dx.doi.org/10.3390/cancers11121926

Ejemplares similares